Moderator
Emma Sceats Chief Executive Officer, CN Bio Innovations Ltd. |
Keynote Speakers
James Hickman Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos |
Michael Shuler Samuel B. Eckert Professor of Engineering, Cornell University, President Hesperos, Inc. |
Tommy Andersson Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, AstraZeneca, Gothenburg |
Linda Griffith Professor, Massachusetts Institute of Technology (MIT) |
Katia Karalis Executive Vice President of Research, Emulate, Inc. |
John Wikswo Gordon A. Cain University Professor, A.B. Learned Professor of Living State Physics; Founding Director, Vanderbilt Institute for Integrative Biosystems, Vanderbilt University |
|
Roger Kamm Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT) |
OverviewSelect Biosciences Third Annual Organ-on-a-Chip World Congress 2017
focuses on an important and expanding field wherein cells are being
assembled using Microfluidics and Lab-on-a-Chip technologies in a
functionally-relevant manner. These clusters of "assembled cells" have
functional significance and can mimic in vivo organ structure. Liver
cells assembled on-board chips in a physiologically-relevant
architecture using microfluidics can, for instance, be utilized for
toxicity screening and the ability to assemble organ fragments ex vivo
can provide an exquisite means to reconstruct biological processes
(both physiological and pathological) "in a dish" or "on a chip." A
number of chips such Lung-on-a-Chip, Brain-on-a-Chip, Gut-on-a-Chip,
Marrow-on-a-Chip, Bone-on-a-Chip, Nerve-on-a-Chip amongst others have
been built and will be presented and explored at this conference. We
will also focus on "disease-on-a-chip", cancer-on-a-chip, immune
system-on-a-chip. Due to the Overlap of this Topic with
3D-Culture and Stem Cells in Drug Discovery, the co-located concurrent
parallel conference tracks focus on these topics thereby offering
complete coverage of these related fields to the conference delegates. Major Themes Addressed in the 3D-Culture Conference: - Using 3D-cultures as a tool for screening in the oncology space in a physiologically-relevant context
- Studies of drug metabolism and the cytochrome P450 pathway facilitated in a physiologically-relevant context
The
Three Conference Tracks are Co-Located and Concurrent and Delegates can
Participate, Mix-and-Match Presentations and Network Extensively with
their Colleagues from all 3 Conference Tracks. The Exhibit hall is co-located and is accessible by delegates from all 3 conference tracks. Co-Located, Concurrent Conference Tracks:
- Organ-on-a-Chip World Congress 2017
- 3D-Culture 2017
- Stem Cells in Drug Discovery & Toxicity Screening 2017
All
the Key Opinion Leaders from around the World are Participating at this
Conference allowing Maximal Information Exchange and Unparalleled
Networking Opportunities.
Session Sponsors
Agenda Topics- 3D-Culture in Liver Toxicity Screening
- Cytochrome P450 Screening Assays
- Liver Biology and Drug Toxicity Screening
- 3D-Culture of Cells as a Means for Physiological Cellular Culture
- 3D-Culture of Cells: Drivers and Approaches
- 3D-Microtissues
- Microscopy, High-Content Screening and 3D-Culture
- Neurospheres
- Using 3D-Cultures as a Tool for Screening in the Oncology Field
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Confirmed Speakers to dateTania Konry, Assistant Professor, Department of Pharmaceutical Sciences, Northeastern University Ashutosh Agarwal, Assistant Professor, Department of Biomedical Engineering, University of Miami Miller School of Medicine Ayesha Arefin, Researcher, University of New Mexico Holger Becker, Chief Scientific Officer, Microfluidic ChipShop GmbH Herman Blok, Business Development Manager, Micronit Microtechnologies Joseph L Charest, Program Manager, Charles Stark Draper Laboratory Thomas Corso, Chief Technical Officer, CorSolutions Brad Dykstra, Senior Research Scientist, Platelet BioGenesis; Brigham and Women’s Hospital and Harvard Medical School Olivier Frey, Vice President Technologies and Platforms, InSphero AG William Gray, Professor of Functional Neurosurgery, Cardiff University School of Medicine Alicia Henn, Chief Scientific Officer, BioSpherix, Ltd. Aiste Jekabsone, Researcher, Lithuanian University of Health Sciences Pulak Nath, Technical Staff Member, Applied Modern Physics, Los Alamos National Laboratory Terry Riss, Senior Product Manager, Cell Health, Promega Corporation Andreas Schober, Head of Department Nano-biosystem Technology, University of Technology Ilmenau, Technische Universitat Ilmenau Orit Shefi, Associate Professor, Head of Neuroengineering Laboratory, Faculty of Engineering and Institute of Nanotechnologies and Advanced Materials, Bar-Ilan University Israel Marjorie Villien, Technology & Market Analyst - Microfluidic & Medical Technologies, Yole Développement Michael Wong, Researcher, Faculty of Health Sciences, McMaster University
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|